Learn More
Human PD-L1/B7-H1 (Research Grade Durvalumab Biosimilar) Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | PD-L1 |
| Applications | Flow Cytometry, CyTOF |
| Classification | Monoclonal |
| Clone | Hu125 |
| Conjugate | Unconjugated |
| Dilution | Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. |
| Gene Alias | Avelumab, B7-H, B7H1, B7-H1, B7H1PDCD1L1, CD274, CD274 antigenMGC142294, CD274 molecule, PDCD1L1, PDCD1LG1, PDCD1LG1MGC142296, PDL1, PD-L1, PD-L1B7 homolog 1, PDL1PDCD1 ligand 1, programmed cell death 1 ligand 1, Programmed death ligand 1 |
| Host Species | Human |
| Immunogen | Human PD-L1/B7-H1, |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.